https://www.gsk.com/en-gb/media/press-releases/gsk-and-valeant-receive-european-authorisation-for-trobalt-retigabine/
GSK & VRX announced, EC has granted marketing authorisation for Trobalt (retigabine) as an add-on treatment of partial onset seizures.
gskvaleantreceiveeuropeanauthorisation